United States Epoprostenol Market Report 2016

November 2016 | 108 pages | ID: UB4B8C672E4EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Epoprostenol

Revenue, means the sales value of Epoprostenol

This report studies sales (consumption) of Epoprostenol in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer, Inc. (US)
• Bayer HealthCare Pharmaceuticals (Germany)
• GlaxoSmithKline Plc (UK)
• Eli Lilly and Company (US)
• Gilead Sciences, Inc. (US)
• Sanofi S.A (France)
• Nippon Shinyaku Co., Ltd. (Japan)
• United Therapeutics Corp. (US)
• Cipla Limited (India)
• YM BioSciences, Inc. (Canada)
• Actelion Pharmaceuticals Ltd. (Switzerland)
• Arena Pharmaceuticals, Inc. (US)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Epoprostenol in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Epoprostenol Market Report 2016

1 EPOPROSTENOL OVERVIEW

1.1 Product Overview and Scope of Epoprostenol
1.2 Classification of Epoprostenol
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Epoprostenol
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Epoprostenol (2011-2021)
  1.4.1 United States Epoprostenol Sales and Growth Rate (2011-2021)
  1.4.2 United States Epoprostenol Revenue and Growth Rate (2011-2021)

2 UNITED STATES EPOPROSTENOL COMPETITION BY MANUFACTURERS

2.1 United States Epoprostenol Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Epoprostenol Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Epoprostenol Average Price by Manufactures (2015 and 2016)
2.4 Epoprostenol Market Competitive Situation and Trends
  2.4.1 Epoprostenol Market Concentration Rate
  2.4.2 Epoprostenol Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES EPOPROSTENOL SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Epoprostenol Sales and Market Share by Type (2011-2016)
3.2 United States Epoprostenol Revenue and Market Share by Type (2011-2016)
3.3 United States Epoprostenol Price by Type (2011-2016)
3.4 United States Epoprostenol Sales Growth Rate by Type (2011-2016)

4 UNITED STATES EPOPROSTENOL SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Epoprostenol Sales and Market Share by Application (2011-2016)
4.2 United States Epoprostenol Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES EPOPROSTENOL MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Epoprostenol Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bayer HealthCare Pharmaceuticals (Germany)
  5.2.2 Epoprostenol Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bayer HealthCare Pharmaceuticals (Germany) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc (UK)
  5.3.2 Epoprostenol Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Plc (UK) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Eli Lilly and Company (US)
  5.4.2 Epoprostenol Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Eli Lilly and Company (US) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Gilead Sciences, Inc. (US)
  5.5.2 Epoprostenol Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Gilead Sciences, Inc. (US) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Sanofi S.A (France)
  5.6.2 Epoprostenol Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Sanofi S.A (France) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Nippon Shinyaku Co., Ltd. (Japan)
  5.7.2 Epoprostenol Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Nippon Shinyaku Co., Ltd. (Japan) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 United Therapeutics Corp. (US)
  5.8.2 Epoprostenol Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 United Therapeutics Corp. (US) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Cipla Limited (India)
  5.9.2 Epoprostenol Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Cipla Limited (India) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 YM BioSciences, Inc. (Canada)
  5.10.2 Epoprostenol Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 YM BioSciences, Inc. (Canada) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Actelion Pharmaceuticals Ltd. (Switzerland)
5.12 Arena Pharmaceuticals, Inc. (US)

6 EPOPROSTENOL MANUFACTURING COST ANALYSIS

6.1 Epoprostenol Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Epoprostenol

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Epoprostenol Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Epoprostenol Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES EPOPROSTENOL MARKET FORECAST (2016-2021)

10.1 United States Epoprostenol Sales, Revenue Forecast (2016-2021)
10.2 United States Epoprostenol Sales Forecast by Type (2016-2021)
10.3 United States Epoprostenol Sales Forecast by Application (2016-2021)
10.4 Epoprostenol Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Epoprostenol
Table Classification of Epoprostenol
Figure United States Sales Market Share of Epoprostenol by Type in 2015
Table Application of Epoprostenol
Figure United States Sales Market Share of Epoprostenol by Application in 2015
Figure United States Epoprostenol Sales and Growth Rate (2011-2021)
Figure United States Epoprostenol Revenue and Growth Rate (2011-2021)
Table United States Epoprostenol Sales of Key Manufacturers (2015 and 2016)
Table United States Epoprostenol Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Epoprostenol Sales Share by Manufacturers
Figure 2016 Epoprostenol Sales Share by Manufacturers
Table United States Epoprostenol Revenue by Manufacturers (2015 and 2016)
Table United States Epoprostenol Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Epoprostenol Revenue Share by Manufacturers
Table 2016 United States Epoprostenol Revenue Share by Manufacturers
Table United States Market Epoprostenol Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Epoprostenol Average Price of Key Manufacturers in 2015
Figure Epoprostenol Market Share of Top 3 Manufacturers
Figure Epoprostenol Market Share of Top 5 Manufacturers
Table United States Epoprostenol Sales by Type (2011-2016)
Table United States Epoprostenol Sales Share by Type (2011-2016)
Figure United States Epoprostenol Sales Market Share by Type in 2015
Table United States Epoprostenol Revenue and Market Share by Type (2011-2016)
Table United States Epoprostenol Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Epoprostenol by Type (2011-2016)
Table United States Epoprostenol Price by Type (2011-2016)
Figure United States Epoprostenol Sales Growth Rate by Type (2011-2016)
Table United States Epoprostenol Sales by Application (2011-2016)
Table United States Epoprostenol Sales Market Share by Application (2011-2016)
Figure United States Epoprostenol Sales Market Share by Application in 2015
Table United States Epoprostenol Sales Growth Rate by Application (2011-2016)
Figure United States Epoprostenol Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Epoprostenol Sales Market Share (2011-2016)
Table Bayer HealthCare Pharmaceuticals (Germany) Basic Information List
Table Bayer HealthCare Pharmaceuticals (Germany) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer HealthCare Pharmaceuticals (Germany) Epoprostenol Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc (UK) Epoprostenol Sales Market Share (2011-2016)
Table Eli Lilly and Company (US) Basic Information List
Table Eli Lilly and Company (US) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company (US) Epoprostenol Sales Market Share (2011-2016)
Table Gilead Sciences, Inc. (US) Basic Information List
Table Gilead Sciences, Inc. (US) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gilead Sciences, Inc. (US) Epoprostenol Sales Market Share (2011-2016)
Table Sanofi S.A (France) Basic Information List
Table Sanofi S.A (France) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A (France) Epoprostenol Sales Market Share (2011-2016)
Table Nippon Shinyaku Co., Ltd. (Japan) Basic Information List
Table Nippon Shinyaku Co., Ltd. (Japan) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nippon Shinyaku Co., Ltd. (Japan) Epoprostenol Sales Market Share (2011-2016)
Table United Therapeutics Corp. (US) Basic Information List
Table United Therapeutics Corp. (US) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
Table United Therapeutics Corp. (US) Epoprostenol Sales Market Share (2011-2016)
Table Cipla Limited (India) Basic Information List
Table Cipla Limited (India) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cipla Limited (India) Epoprostenol Sales Market Share (2011-2016)
Table YM BioSciences, Inc. (Canada) Basic Information List
Table YM BioSciences, Inc. (Canada) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
Table YM BioSciences, Inc. (Canada) Epoprostenol Sales Market Share (2011-2016)
Table Actelion Pharmaceuticals Ltd. (Switzerland) Basic Information List
Table Actelion Pharmaceuticals Ltd. (Switzerland) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
Table Actelion Pharmaceuticals Ltd. (Switzerland) Epoprostenol Sales Market Share (2011-2016)
Table Arena Pharmaceuticals, Inc. (US) Basic Information List
Table Arena Pharmaceuticals, Inc. (US) Epoprostenol Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arena Pharmaceuticals, Inc. (US) Epoprostenol Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Epoprostenol
Figure Manufacturing Process Analysis of Epoprostenol
Figure Epoprostenol Industrial Chain Analysis
Table Raw Materials Sources of Epoprostenol Major Manufacturers in 2015
Table Major Buyers of Epoprostenol
Table Distributors/Traders List
Figure United States Epoprostenol Production and Growth Rate Forecast (2016-2021)
Figure United States Epoprostenol Revenue and Growth Rate Forecast (2016-2021)
Table United States Epoprostenol Production Forecast by Type (2016-2021)
Table United States Epoprostenol Consumption Forecast by Application (2016-2021)